The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cabergoline API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Cabergoline API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1752239

No of Pages : 93

Ask Your Query

Synopsis
The global Cabergoline API market size was valued at USD 6 million in 2022 and is forecast to a readjusted size of USD 8 million by 2029 with a CAGR of 4.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global 5 largest manufacturers of Cabergoline API are Teva API, Finetech Pharma, Global Biologicals, Alven Laboratories and Wellona Pharma, which make up over 80%. Among them, Teva API dominates with over 30% production value share, followed by Finetech Pharma (25%) and Global Biologicals (20%). Top manufacturers are based in Israel, China and India.

Europe is the largest market, holding a share nearly 40%, followed by North America and Asia-Pacific, with shares 30% and 20% separately.

Based on the product type, the Cabergoline API is primarily split into Purity below 95%, Purity from 95% to 98% and Purity above 98%. The leading type is Cabergoline API of Purity from 95% to 98%, with a market share nearly 50%.

Based on the product Application, the Cabergoline API is primarily split into Anti-Parkinson, Hyperprolactinemic Disorders and Others. The largest segment is Hyperprolactinemic Disorders, accounting for nearly 75%.

Cabergoline API is the main ingredient of cabergoline in a medicine that causes the desired effect of the medicine. Cabergoline is an ergot derivative and a potent dopamine D2 receptor agonist. Cabergoline was patented in 1980 and approved for medical use in 1993.

This report is a detailed and comprehensive analysis for global Cabergoline API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Cabergoline API market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2018-2029
Global Cabergoline API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2018-2029
Global Cabergoline API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/g), 2018-2029
Global Cabergoline API market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/g), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Cabergoline API
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global Cabergoline API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva API, Finetech Pharma, Global Biologicals, Wellona Pharma and Alven Laboratories and etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Cabergoline API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Purity less than 95%
  • Purity 95%-98%
  • Purity more than 98%

Market segment by Application

  • Anti-Parkinson
  • Hyperprolactinemic Disorders
  • Others

Major players covered

  • Teva API
  • Finetech Pharma
  • Global Biologicals
  • Wellona Pharma
  • Alven Laboratories
  • Salvavidas Pharmaceutical

Market segment by region, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Cabergoline API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cabergoline API, with price, sales, revenue and global market share of Cabergoline API from 2018 to 2023.
Chapter 3, the Cabergoline API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cabergoline API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cabergoline API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cabergoline API.
Chapter 14 and 15, to describe Cabergoline API sales channel, distributors, customers, research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Cabergoline API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cabergoline API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Purity less than 95%
1.3.3 Purity 95%-98%
1.3.4 Purity more than 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Cabergoline API Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Anti-Parkinson
1.4.3 Hyperprolactinemic Disorders
1.4.4 Others
1.5 Global Cabergoline API Market Size & Forecast
1.5.1 Global Cabergoline API Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Cabergoline API Sales Quantity (2018-2029)
1.5.3 Global Cabergoline API Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Teva API
2.1.1 Teva API Details
2.1.2 Teva API Major Business
2.1.3 Teva API Cabergoline API Product and Services
2.1.4 Teva API Cabergoline API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teva API Recent Developments/Updates
2.2 Finetech Pharma
2.2.1 Finetech Pharma Details
2.2.2 Finetech Pharma Major Business
2.2.3 Finetech Pharma Cabergoline API Product and Services
2.2.4 Finetech Pharma Cabergoline API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Finetech Pharma Recent Developments/Updates
2.3 Global Biologicals
2.3.1 Global Biologicals Details
2.3.2 Global Biologicals Major Business
2.3.3 Global Biologicals Cabergoline API Product and Services
2.3.4 Global Biologicals Cabergoline API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Global Biologicals Recent Developments/Updates
2.4 Wellona Pharma
2.4.1 Wellona Pharma Details
2.4.2 Wellona Pharma Major Business
2.4.3 Wellona Pharma Cabergoline API Product and Services
2.4.4 Wellona Pharma Cabergoline API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Wellona Pharma Recent Developments/Updates
2.5 Alven Laboratories
2.5.1 Alven Laboratories Details
2.5.2 Alven Laboratories Major Business
2.5.3 Alven Laboratories Cabergoline API Product and Services
2.5.4 Alven Laboratories Cabergoline API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Alven Laboratories Recent Developments/Updates
2.6 Salvavidas Pharmaceutical
2.6.1 Salvavidas Pharmaceutical Details
2.6.2 Salvavidas Pharmaceutical Major Business
2.6.3 Salvavidas Pharmaceutical Cabergoline API Product and Services
2.6.4 Salvavidas Pharmaceutical Cabergoline API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Salvavidas Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Cabergoline API by Manufacturer
3.1 Global Cabergoline API Sales Quantity by Manufacturer (2018-2023)
3.2 Global Cabergoline API Revenue by Manufacturer (2018-2023)
3.3 Global Cabergoline API Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Cabergoline API by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Cabergoline API Manufacturer Market Share in 2022
3.4.2 Top 6 Cabergoline API Manufacturer Market Share in 2022
3.5 Cabergoline API Market: Overall Company Footprint Analysis
3.5.1 Cabergoline API Market: Region Footprint
3.5.2 Cabergoline API Market: Company Product Type Footprint
3.5.3 Cabergoline API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Cabergoline API Market Size by Region
4.1.1 Global Cabergoline API Sales Quantity by Region (2018-2029)
4.1.2 Global Cabergoline API Consumption Value by Region (2018-2029)
4.1.3 Global Cabergoline API Average Price by Region (2018-2029)
4.2 North America Cabergoline API Consumption Value (2018-2029)
4.3 Europe Cabergoline API Consumption Value (2018-2029)
4.4 Asia-Pacific Cabergoline API Consumption Value (2018-2029)
4.5 South America Cabergoline API Consumption Value (2018-2029)
4.6 Middle East and Africa Cabergoline API Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Cabergoline API Sales Quantity by Type (2018-2029)
5.2 Global Cabergoline API Consumption Value by Type (2018-2029)
5.3 Global Cabergoline API Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Cabergoline API Sales Quantity by Application (2018-2029)
6.2 Global Cabergoline API Consumption Value by Application (2018-2029)
6.3 Global Cabergoline API Average Price by Application (2018-2029)
7 North America
7.1 North America Cabergoline API Sales Quantity by Type (2018-2029)
7.2 North America Cabergoline API Sales Quantity by Application (2018-2029)
7.3 North America Cabergoline API Market Size by Country
7.3.1 North America Cabergoline API Sales Quantity by Country (2018-2029)
7.3.2 North America Cabergoline API Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Cabergoline API Sales Quantity by Type (2018-2029)
8.2 Europe Cabergoline API Sales Quantity by Application (2018-2029)
8.3 Europe Cabergoline API Market Size by Country
8.3.1 Europe Cabergoline API Sales Quantity by Country (2018-2029)
8.3.2 Europe Cabergoline API Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Cabergoline API Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Cabergoline API Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Cabergoline API Market Size by Region
9.3.1 Asia-Pacific Cabergoline API Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Cabergoline API Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Cabergoline API Sales Quantity by Type (2018-2029)
10.2 South America Cabergoline API Sales Quantity by Application (2018-2029)
10.3 South America Cabergoline API Market Size by Country
10.3.1 South America Cabergoline API Sales Quantity by Country (2018-2029)
10.3.2 South America Cabergoline API Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Cabergoline API Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Cabergoline API Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Cabergoline API Market Size by Country
11.3.1 Middle East & Africa Cabergoline API Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Cabergoline API Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Cabergoline API Market Drivers
12.2 Cabergoline API Market Restraints
12.3 Cabergoline API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Cabergoline API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cabergoline API
13.3 Cabergoline API Production Process
13.4 Cabergoline API Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cabergoline API Typical Distributors
14.3 Cabergoline API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock